The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

OBJECTIVE: A 50-100-mg rectal dose of nonsteroidal anti-inflammatory drugs (NSAIDs; diclofenac or indomethacin) has been shown to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). However, this is higher than the recommended 25-mg dose that is commonly administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuno, Mitsuru, Shiroko, Junko, Taguchi, Daisuke, Yamaguchi, Kimihiro, Takada, Jun, Imai, Susumu, Sato, Hiroyuki, Thanabashi, Shinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148161/
https://www.ncbi.nlm.nih.gov/pubmed/29607957
http://dx.doi.org/10.2169/internalmedicine.0554-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148161/
https://www.ncbi.nlm.nih.gov/pubmed/29607957
http://dx.doi.org/10.2169/internalmedicine.0554-17

Ejemplares similares